This compound is a pharmaceutical impurity reference standard used for analytical testing and quality control in drug development. It is structurally characterized as a chloro-propanone derivative of a pyrazolopyrimidine scaffold, with multiple aromatic rings and an ether linkage.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1288338-96-4
1-((R)-3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-((S)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one
pharmaceutical reference standard impurity
Ibrutinib, (S)-
active pharmaceutical ingredient
Tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
n.a
1-(phenylsulfonyl)-1H-indol-3-ylboronic acid
boronic acid building block
4,4'-(Ethyne-1,2-diyl)diphthalic Anhydride
chemical intermediate for advanced materials
1,3-bis(2,2-difluoropropanoyloxy)propan-2-yl 2-methylprop-2-enoate
Polymerizable monomer for coatings
3,4,5-Trifluoro-4'-(trans-4-propylcyclohexyl)-1,1'-biphenyl
liquid crystal intermediate
Ibrutinib acetyl impurity
n.a
1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one
VJQOEGZWPHTCTQ-GOSISDBHSA-N
C1C[C@H](CN(C1)C(=O)CCCl)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N